Marex (MRX) Cash & Equivalents (2022 - 2026)

Marex (MRX) has reported Cash & Equivalents for 5 consecutive years, with $3.9 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 14.09% year-over-year to $3.9 billion; the trailing twelve-month figure through Jun 2026 stood at $3.9 billion (up 14.09% YoY), and the FY2025 full-year result was $2.9 billion, up 12.7% from the prior year.
• Cash & Equivalents rose to $3.9 billion in Q2 2026 per MRX's latest filing, from $3.1 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $3.9 billion in Q2 2026 and bottomed at $910.1 million in Q4 2022.
• Historically, Cash & Equivalents has averaged $2.6 billion across 5 years, with a median of $2.7 billion in 2025.
• The widest YoY moves for Cash & Equivalents: up 76.33% in 2025, down 12.7% in 2025.
• Over 5 years, Cash & Equivalents stood at $910.1 million in 2022, then surged by 63.0% to $1.5 billion in 2023, then surged by 72.34% to $2.6 billion in 2024, then climbed by 12.7% to $2.9 billion in 2025, then soared by 33.66% to $3.9 billion in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $3.9 billion, $3.1 billion, and $2.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.